nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2C8—Paclitaxel—ovarian cancer	0.136	0.167	CbGbCtD
Brompheniramine—CYP2D6—Vinorelbine—ovarian cancer	0.124	0.152	CbGbCtD
Brompheniramine—CYP3A4—Topotecan—ovarian cancer	0.112	0.137	CbGbCtD
Brompheniramine—CYP2B6—Doxorubicin—ovarian cancer	0.097	0.119	CbGbCtD
Brompheniramine—CYP2C9—Paclitaxel—ovarian cancer	0.0951	0.117	CbGbCtD
Brompheniramine—CYP3A4—Vinorelbine—ovarian cancer	0.0787	0.0966	CbGbCtD
Brompheniramine—CYP3A4—Paclitaxel—ovarian cancer	0.0553	0.0679	CbGbCtD
Brompheniramine—CYP2D6—Doxorubicin—ovarian cancer	0.0469	0.0575	CbGbCtD
Brompheniramine—CYP3A4—Docetaxel—ovarian cancer	0.04	0.0491	CbGbCtD
Brompheniramine—CHRM3—muscle of abdomen—ovarian cancer	0.0361	0.239	CbGeAlD
Brompheniramine—CYP3A4—Doxorubicin—ovarian cancer	0.0298	0.0366	CbGbCtD
Brompheniramine—CHRM5—epithelium—ovarian cancer	0.0077	0.0508	CbGeAlD
Brompheniramine—CHRM4—testis—ovarian cancer	0.0059	0.039	CbGeAlD
Brompheniramine—KCNH2—myometrium—ovarian cancer	0.00486	0.0321	CbGeAlD
Brompheniramine—HRH1—myometrium—ovarian cancer	0.0039	0.0257	CbGeAlD
Brompheniramine—KCNH2—uterine cervix—ovarian cancer	0.00378	0.025	CbGeAlD
Brompheniramine—CHRM1—female reproductive system—ovarian cancer	0.00357	0.0236	CbGeAlD
Brompheniramine—KCNH2—endometrium—ovarian cancer	0.00342	0.0226	CbGeAlD
Brompheniramine—CHRM3—female reproductive system—ovarian cancer	0.0032	0.0211	CbGeAlD
Brompheniramine—KCNH2—uterus—ovarian cancer	0.00315	0.0208	CbGeAlD
Brompheniramine—CYP2C8—endometrium—ovarian cancer	0.00313	0.0207	CbGeAlD
Brompheniramine—HRH1—epithelium—ovarian cancer	0.00306	0.0202	CbGeAlD
Brompheniramine—HRH1—uterine cervix—ovarian cancer	0.00303	0.02	CbGeAlD
Brompheniramine—CHRM3—female gonad—ovarian cancer	0.00291	0.0192	CbGeAlD
Brompheniramine—HRH1—decidua—ovarian cancer	0.00289	0.0191	CbGeAlD
Brompheniramine—KCNH2—female reproductive system—ovarian cancer	0.00283	0.0187	CbGeAlD
Brompheniramine—HRH1—endometrium—ovarian cancer	0.00274	0.0181	CbGeAlD
Brompheniramine—CYP2C19—vagina—ovarian cancer	0.00269	0.0177	CbGeAlD
Brompheniramine—KCNH2—bone marrow—ovarian cancer	0.00268	0.0177	CbGeAlD
Brompheniramine—CYP2B6—gonad—ovarian cancer	0.0026	0.0172	CbGeAlD
Brompheniramine—CYP2C8—female reproductive system—ovarian cancer	0.00259	0.0171	CbGeAlD
Brompheniramine—CHRM3—testis—ovarian cancer	0.00258	0.017	CbGeAlD
Brompheniramine—KCNH2—female gonad—ovarian cancer	0.00258	0.017	CbGeAlD
Brompheniramine—KCNH2—vagina—ovarian cancer	0.00256	0.0169	CbGeAlD
Brompheniramine—CYP2C8—vagina—ovarian cancer	0.00235	0.0155	CbGeAlD
Brompheniramine—CYP2B6—female reproductive system—ovarian cancer	0.00233	0.0154	CbGeAlD
Brompheniramine—CYP2C9—female reproductive system—ovarian cancer	0.0023	0.0152	CbGeAlD
Brompheniramine—KCNH2—testis—ovarian cancer	0.00229	0.0151	CbGeAlD
Brompheniramine—HRH1—female reproductive system—ovarian cancer	0.00227	0.015	CbGeAlD
Brompheniramine—CYP2E1—female reproductive system—ovarian cancer	0.00218	0.0144	CbGeAlD
Brompheniramine—CYP2B6—vagina—ovarian cancer	0.0021	0.0139	CbGeAlD
Brompheniramine—CYP2C8—testis—ovarian cancer	0.00209	0.0138	CbGeAlD
Brompheniramine—HRH1—female gonad—ovarian cancer	0.00207	0.0136	CbGeAlD
Brompheniramine—HRH1—vagina—ovarian cancer	0.00205	0.0136	CbGeAlD
Brompheniramine—CYP2B6—testis—ovarian cancer	0.00188	0.0124	CbGeAlD
Brompheniramine—HRH1—testis—ovarian cancer	0.00183	0.0121	CbGeAlD
Brompheniramine—CYP2E1—testis—ovarian cancer	0.00176	0.0116	CbGeAlD
Brompheniramine—CYP3A4—female reproductive system—ovarian cancer	0.00176	0.0116	CbGeAlD
Brompheniramine—CYP2D6—female reproductive system—ovarian cancer	0.00173	0.0114	CbGeAlD
Brompheniramine—KCNH2—lymph node—ovarian cancer	0.00166	0.0109	CbGeAlD
Brompheniramine—CYP2D6—female gonad—ovarian cancer	0.00157	0.0104	CbGeAlD
Brompheniramine—CYP2D6—testis—ovarian cancer	0.0014	0.00921	CbGeAlD
Brompheniramine—HRH1—lymph node—ovarian cancer	0.00133	0.00877	CbGeAlD
Brompheniramine—HRH1—Signaling by GPCR—NRAS—ovarian cancer	7.95e-06	0.000233	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CASP3—ovarian cancer	7.93e-06	0.000232	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CG—ovarian cancer	7.93e-06	0.000232	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—APC—ovarian cancer	7.93e-06	0.000232	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—NRAS—ovarian cancer	7.93e-06	0.000232	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2—ovarian cancer	7.92e-06	0.000232	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CG—ovarian cancer	7.9e-06	0.000231	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—APC—ovarian cancer	7.9e-06	0.000231	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—NRAS—ovarian cancer	7.9e-06	0.000231	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—ovarian cancer	7.88e-06	0.000231	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ABCB1—ovarian cancer	7.84e-06	0.000229	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—ovarian cancer	7.83e-06	0.000229	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—APC—ovarian cancer	7.83e-06	0.000229	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CG—ovarian cancer	7.83e-06	0.000229	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—NRAS—ovarian cancer	7.83e-06	0.000229	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PTEN—ovarian cancer	7.78e-06	0.000228	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ABCB1—ovarian cancer	7.77e-06	0.000227	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCND1—ovarian cancer	7.72e-06	0.000226	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TYMS—ovarian cancer	7.7e-06	0.000225	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CTNNB1—ovarian cancer	7.65e-06	0.000224	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TYMS—ovarian cancer	7.63e-06	0.000223	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—MAPK3—ovarian cancer	7.62e-06	0.000223	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—AKT1—ovarian cancer	7.59e-06	0.000222	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—MAPK3—ovarian cancer	7.59e-06	0.000222	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—MAPK3—ovarian cancer	7.57e-06	0.000221	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CAV1—ovarian cancer	7.56e-06	0.000221	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—ovarian cancer	7.5e-06	0.000219	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—MAPK3—ovarian cancer	7.49e-06	0.000219	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PTEN—ovarian cancer	7.45e-06	0.000218	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—AKT1—ovarian cancer	7.27e-06	0.000213	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—MAPK1—ovarian cancer	7.25e-06	0.000212	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—ovarian cancer	7.25e-06	0.000212	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CB—ovarian cancer	7.24e-06	0.000212	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—MAPK1—ovarian cancer	7.22e-06	0.000211	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—ovarian cancer	7.22e-06	0.000211	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.22e-06	0.000211	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—MAPK1—ovarian cancer	7.2e-06	0.000211	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—ovarian cancer	7.2e-06	0.000211	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	7.15e-06	0.000209	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—MAPK1—ovarian cancer	7.13e-06	0.000209	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—ovarian cancer	7.13e-06	0.000209	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—ovarian cancer	7.03e-06	0.000206	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	7e-06	0.000205	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CD—ovarian cancer	6.99e-06	0.000205	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CD—ovarian cancer	6.97e-06	0.000204	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—ovarian cancer	6.96e-06	0.000204	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CD—ovarian cancer	6.95e-06	0.000203	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NRAS—ovarian cancer	6.95e-06	0.000203	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PIK3CA—ovarian cancer	6.93e-06	0.000203	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	6.9e-06	0.000202	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	6.88e-06	0.000201	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PIK3CA—ovarian cancer	6.88e-06	0.000201	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CD—ovarian cancer	6.88e-06	0.000201	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—KRAS—ovarian cancer	6.84e-06	0.0002	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—FASN—ovarian cancer	6.83e-06	0.0002	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—KRAS—ovarian cancer	6.82e-06	0.0002	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PIK3CA—ovarian cancer	6.81e-06	0.000199	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—KRAS—ovarian cancer	6.8e-06	0.000199	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CAV1—ovarian cancer	6.74e-06	0.000197	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—KRAS—ovarian cancer	6.74e-06	0.000197	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—ovarian cancer	6.73e-06	0.000197	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.72e-06	0.000197	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—ovarian cancer	6.67e-06	0.000195	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK3—ovarian cancer	6.65e-06	0.000195	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NRAS—ovarian cancer	6.65e-06	0.000195	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	6.49e-06	0.00019	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—ovarian cancer	6.47e-06	0.000189	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.44e-06	0.000189	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK3—ovarian cancer	6.37e-06	0.000186	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK1—ovarian cancer	6.33e-06	0.000185	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—ovarian cancer	6.33e-06	0.000185	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CA—ovarian cancer	6.29e-06	0.000184	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CA—ovarian cancer	6.27e-06	0.000183	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—ovarian cancer	6.26e-06	0.000183	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CA—ovarian cancer	6.25e-06	0.000183	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	6.23e-06	0.000182	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.22e-06	0.000182	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CAV1—ovarian cancer	6.2e-06	0.000182	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—ovarian cancer	6.2e-06	0.000181	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CA—ovarian cancer	6.19e-06	0.000181	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB2—ovarian cancer	6.18e-06	0.000181	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB2—ovarian cancer	6.16e-06	0.00018	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CAV1—ovarian cancer	6.15e-06	0.00018	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	6.14e-06	0.00018	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB2—ovarian cancer	6.14e-06	0.00018	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	6.1e-06	0.000179	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CB—ovarian cancer	6.09e-06	0.000178	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MTOR—ovarian cancer	6.09e-06	0.000178	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB2—ovarian cancer	6.08e-06	0.000178	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MTOR—ovarian cancer	6.07e-06	0.000178	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CB—ovarian cancer	6.07e-06	0.000178	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK1—ovarian cancer	6.06e-06	0.000177	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—ovarian cancer	6.06e-06	0.000177	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CB—ovarian cancer	6.06e-06	0.000177	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MTOR—ovarian cancer	6.06e-06	0.000177	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	6.05e-06	0.000177	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CB—ovarian cancer	6e-06	0.000175	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MTOR—ovarian cancer	6e-06	0.000175	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KRAS—ovarian cancer	5.98e-06	0.000175	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.88e-06	0.000172	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—ovarian cancer	5.86e-06	0.000171	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—ovarian cancer	5.84e-06	0.000171	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—ovarian cancer	5.82e-06	0.00017	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRAS—ovarian cancer	5.82e-06	0.00017	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRAS—ovarian cancer	5.8e-06	0.00017	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRAS—ovarian cancer	5.78e-06	0.000169	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—ovarian cancer	5.76e-06	0.000169	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRAS—ovarian cancer	5.72e-06	0.000168	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KRAS—ovarian cancer	5.72e-06	0.000167	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1B—ovarian cancer	5.72e-06	0.000167	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1B—ovarian cancer	5.7e-06	0.000167	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1B—ovarian cancer	5.68e-06	0.000166	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—ovarian cancer	5.66e-06	0.000166	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	5.65e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—ovarian cancer	5.64e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1B—ovarian cancer	5.63e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—ovarian cancer	5.62e-06	0.000164	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CASP3—ovarian cancer	5.61e-06	0.000164	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.6e-06	0.000164	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—ovarian cancer	5.6e-06	0.000164	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CASP3—ovarian cancer	5.59e-06	0.000163	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—ovarian cancer	5.58e-06	0.000163	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CASP3—ovarian cancer	5.57e-06	0.000163	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—ovarian cancer	5.57e-06	0.000163	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—ovarian cancer	5.57e-06	0.000163	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—ovarian cancer	5.56e-06	0.000163	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—ovarian cancer	5.55e-06	0.000162	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—ovarian cancer	5.53e-06	0.000162	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.52e-06	0.000162	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CASP3—ovarian cancer	5.52e-06	0.000161	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—ovarian cancer	5.51e-06	0.000161	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CA—ovarian cancer	5.49e-06	0.000161	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—ovarian cancer	5.48e-06	0.00016	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—ovarian cancer	5.46e-06	0.00016	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—ovarian cancer	5.44e-06	0.000159	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—ovarian cancer	5.42e-06	0.000159	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CTNNB1—ovarian cancer	5.4e-06	0.000158	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	5.4e-06	0.000158	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CTNNB1—ovarian cancer	5.39e-06	0.000158	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—ovarian cancer	5.38e-06	0.000158	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—ovarian cancer	5.37e-06	0.000157	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CTNNB1—ovarian cancer	5.37e-06	0.000157	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CTNNB1—ovarian cancer	5.32e-06	0.000156	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—ovarian cancer	5.31e-06	0.000155	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—ovarian cancer	5.3e-06	0.000155	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—ovarian cancer	5.28e-06	0.000154	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	5.27e-06	0.000154	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—ovarian cancer	5.27e-06	0.000154	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—ovarian cancer	5.27e-06	0.000154	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—ovarian cancer	5.26e-06	0.000154	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CA—ovarian cancer	5.26e-06	0.000154	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—ovarian cancer	5.25e-06	0.000154	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—ovarian cancer	5.23e-06	0.000153	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—ovarian cancer	5.21e-06	0.000152	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—ovarian cancer	5.18e-06	0.000152	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—ovarian cancer	5.14e-06	0.00015	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.13e-06	0.00015	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	5.12e-06	0.00015	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	5.1e-06	0.000149	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—ovarian cancer	5.09e-06	0.000149	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRAS—ovarian cancer	5.08e-06	0.000149	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	5.05e-06	0.000148	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TYMS—ovarian cancer	5.03e-06	0.000147	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	4.97e-06	0.000145	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.92e-06	0.000144	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRAS—ovarian cancer	4.87e-06	0.000142	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—ovarian cancer	4.86e-06	0.000142	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	4.76e-06	0.000139	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	4.74e-06	0.000139	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	4.73e-06	0.000138	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—ovarian cancer	4.71e-06	0.000138	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.71e-06	0.000138	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NRAS—ovarian cancer	4.7e-06	0.000137	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	4.69e-06	0.000137	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	4.68e-06	0.000137	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	4.68e-06	0.000137	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—ovarian cancer	4.68e-06	0.000137	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NRAS—ovarian cancer	4.67e-06	0.000137	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—ovarian cancer	4.66e-06	0.000136	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	4.63e-06	0.000136	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	4.62e-06	0.000135	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—ovarian cancer	4.56e-06	0.000133	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	4.5e-06	0.000132	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—ovarian cancer	4.49e-06	0.000131	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	4.48e-06	0.000131	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	4.47e-06	0.000131	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	4.43e-06	0.00013	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CA—ovarian cancer	4.41e-06	0.000129	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—ovarian cancer	4.38e-06	0.000128	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—ovarian cancer	4.36e-06	0.000128	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—ovarian cancer	4.35e-06	0.000127	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.33e-06	0.000127	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—ovarian cancer	4.31e-06	0.000126	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—ovarian cancer	4.3e-06	0.000126	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	4.29e-06	0.000126	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	4.28e-06	0.000125	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—ovarian cancer	4.28e-06	0.000125	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	4.27e-06	0.000125	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	4.27e-06	0.000125	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	4.25e-06	0.000124	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—ovarian cancer	4.25e-06	0.000124	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	4.21e-06	0.000123	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	4.21e-06	0.000123	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—ovarian cancer	4.07e-06	0.000119	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAV1—ovarian cancer	4.06e-06	0.000119	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KRAS—ovarian cancer	4.04e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	4.03e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KRAS—ovarian cancer	4.02e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	3.98e-06	0.000116	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	3.8e-06	0.000111	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—ovarian cancer	3.74e-06	0.000109	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.72e-06	0.000109	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	3.71e-06	0.000109	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—ovarian cancer	3.71e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	3.7e-06	0.000108	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.69e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	3.69e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	3.66e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—ovarian cancer	3.61e-06	0.000106	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—ovarian cancer	3.59e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—ovarian cancer	3.58e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—ovarian cancer	3.57e-06	0.000104	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—ovarian cancer	3.54e-06	0.000103	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRAS—ovarian cancer	3.44e-06	0.000101	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	3.43e-06	0.0001	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRAS—ovarian cancer	3.42e-06	9.99e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	3.38e-06	9.9e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—ovarian cancer	3.29e-06	9.63e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—ovarian cancer	3.28e-06	9.59e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—ovarian cancer	3.27e-06	9.56e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.25e-06	9.5e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—ovarian cancer	3.24e-06	9.47e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	3.22e-06	9.41e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—ovarian cancer	3.1e-06	9.08e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—ovarian cancer	3.04e-06	8.89e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—ovarian cancer	3.03e-06	8.88e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	3.03e-06	8.85e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—ovarian cancer	3.02e-06	8.82e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	2.99e-06	8.74e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.87e-06	8.4e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.83e-06	8.28e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.64e-06	7.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—ovarian cancer	2.63e-06	7.68e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.62e-06	7.66e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—ovarian cancer	2.45e-06	7.16e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—ovarian cancer	2.34e-06	6.86e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—ovarian cancer	2.16e-06	6.31e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—ovarian cancer	2.14e-06	6.25e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.73e-06	5.05e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.41e-06	4.12e-05	CbGpPWpGaD
